echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > The Production Process of 9([1,1`-biphenyl]-4-yl)-10-broMo-2-phenylanthracene

    The Production Process of 9([1,1`-biphenyl]-4-yl)-10-broMo-2-phenylanthracene

    • Last Update: 2023-05-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The production process of (1,1`-biphenyl]-4-yl)-10-broMo-2-phenylanthracene, also known as BPAS, is a complex and multi-step process that involves several chemical reactions.
    The starting materials for the production of BPAS are anthracene and molybdenum trioxide, which are reacted in a series of steps to form the final product.


    The first step in the production process is the synthesis of 4-bromoanthracene, which is done by reacting anthracene with bromine in the presence of a solvent such as benzene or dichloromethane.
    The reaction is exothermic and requires careful control to prevent overheating.
    The resulting 4-bromoanthracene is then purified by precipitation with a solvent such as ether or hexane.


    The next step is the synthesis of 1,1`-biphenyl]-4-yl)-10-broMo-2-phenylanthracene, which is done by reacting 4-bromoanthracene with molybdenum trioxide in the presence of a solvent such as toluene or xylene.
    This reaction is also exothermic and requires careful control to prevent overheating.
    The resulting product is then purified by precipitation with a solvent such as ether or hexane, and the final product is obtained by recrystallization from a solvent such as toluene or benzene.


    The entire production process involves several steps, and each step must be carried out with precision to ensure the highest quality product.
    The production process is also environmentally friendly, as the starting materials and byproducts are all relatively harmless chemicals.


    The production of BPAS is a complex process, but it is a routine process in the chemical industry.
    The final product is a valuable material that is used in a variety of applications, including in the production of organic light-emitting diodes (OLEDs) and other electronic devices.
    The high demand for BPAS and its derivatives makes the production process a critical part of the overall supply chain for these products.


    In conclusion, the production process of (1,1`-biphenyl]-4-yl)-10-broMo-2-phenylanthracene is a complex and multi-step process that involves several chemical reactions.
    The starting materials for the production of BPAS are anthracene and molybdenum trioxide, which are reacted in a series of steps to form the final product.
    The entire production process is carried out with precision to ensure the highest quality product, and the final product is a valuable material that is used in a variety of applications.
    The production process of BPAS is a critical part of the overall supply chain for these products, and it is a routine process in the chemical industry.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.